Wholesale QSC Tirzepatide 2023788-19-2 - GMP Standard Manufacturer

QSC Tirzepatide is a novel dual GLP-1 and GIP receptor agonist primarily developed for type 2 diabetes management and weight loss research. This synthetic peptide demonstrates superior metabolic effects through its unique dual mechanism of action.

The compound enhances insulin secretion while simultaneously suppressing glucagon release, but only in the presence of elevated blood glucose levels. This glucose-dependent action makes QSC tirzepatide particularly valuable for metabolic research applications.

Research indicates QSC tirzepatide may offer several advantages for metabolic studies:

• Significant weight reduction effects in clinical trials
• Improved glycemic control parameters
• Potential cardiovascular benefits
• Favorable safety profile in research settings

Our QSC tirzepatide is produced under strict GMP conditions with comprehensive quality control. The white powder form ensures easy handling and preparation for research applications. Each batch undergoes rigorous analytical testing including HPLC purity verification and mass spectrometry confirmation.

Important Note: This product is intended for research use only, not for human consumption. Proper handling procedures should be followed by qualified researchers in controlled laboratory environments.